Ethylene Oxide Residue Testing for Masks: Standards, Methods and Acceptance Limits

Ethylene oxide (EO) residue testing is a critical safety and quality control requirement for masks sterilized with ethylene oxide gas, ensuring that residual sterilant levels remain below the strict limits defined by GB and ISO standards. This article explains the applicable standards, sampling requirements, analytical procedures based on headspace gas chromatography, and acceptance limits governing EO residue determination for medical masks and respirators.

Technical Overview

Ethylene oxide (EO, C2H4O) is one of the most widely used sterilizing agents for disposable medical masks because it is effective at low temperatures, penetrates breathable packaging, and does not degrade the polypropylene melt-blown filtration layers that can be damaged by heat or excessive irradiation. However, EO is a reactive alkylating agent: it is irritating to the skin, eyes, and respiratory tract, it is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC), and its degradation or reaction products, such as ethylene glycol (EG) and 2-chloroethanol (ECH), also carry toxicological concerns. For these reasons, masks sterilized with EO must undergo an aeration cycle and, more importantly, analytical verification that residual EO has dissipated to a safe level.

The determination of EO residue in masks is primarily governed by the following standards framework:

• GB/T 14233.1 (Medical infusion, transfusion and injection equipment - Part 1: Chemical analysis methods), which specifies the gas chromatographic methods for determining EO residues, including headspace gas chromatography.
• GB 19083 (Technical requirements for protective face mask for medical use), YY 0469 (Medical surgical mask), and YY/T 0969 (Single-use medical mask), which stipulate that EO residue shall not exceed 10 micrograms per gram (10 ug/g) for masks sterilized by ethylene oxide.
• ISO 10993-7 (Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals), adopted in China as GB/T 16886.7, which establishes tolerable limits for EO and its by-products based on device contact duration and total delivered dose per device.

In practice, testing is performed by accredited third-party laboratories or in-house quality control facilities using headspace gas chromatography with a flame ionization detector (HS-GC-FID), which offers the sensitivity, selectivity, and throughput required for routine batch release and regulatory submission.

Testing Samples

Medical Protective Masks

Medical protective face masks covered by GB 19083 are high-filtration respiratory protective devices intended for use in high-risk clinical environments. When these products are sterilized by EO, residual EO must be verified against the 10 ug/g limit prior to release.

Medical Surgical Masks

Surgical masks conforming to YY 0469 are worn by clinical staff during invasive procedures. EO-sterilized surgical masks are routinely sampled for residual EO determination as part of factory release testing and market surveillance.

Single-Use Medical Masks

General-purpose single-use medical masks under YY/T 0969 that are sterilized with EO fall within the scope of residual testing. Even though these masks are intended for lower-risk applications, the same residue limit applies.

Filtering Facepiece Respirators

Particulate respirators such as KN95, N95, and FFP-type devices sterilized with EO gas are tested to demonstrate that aeration has reduced residues to compliant levels, particularly when the products are placed on regulated medical device markets.

Sampling and Sample Handling

Representative samples should be taken from finished, packaged units after the completion of the full sterilization and aeration cycle. Samples must be sealed immediately in inert, gas-tight containers, such as aluminum-lined composite pouches or sealed glass vessels, to prevent further dissipation or cross-contamination of EO. Samples should be transported promptly and tested as soon as practicable, since EO residues decline continuously over time. A typical test portion consists of one whole mask or a minimum of several grams of material taken from the body of the mask, cut into small pieces of approximately 5 mm square.

Testing Items

The core testing program for EO-sterilized masks includes the following residual analytes:

• Ethylene oxide (EO) residue: the primary sterilant residue; the acceptance criterion for masks under the GB/YY product standards is not more than 10 ug/g of sample.
• 2-Chloroethanol (ECH, ethylene chlorohydrin) residue: a reaction product of EO with chloride-containing materials or environments, evaluated according to the tolerable limit framework of ISO 10993-7 where applicable.
• Ethylene glycol (EG) residue: a hydrolysis product of EO, considered in the toxicological assessment of sterilization residuals for devices with prolonged patient contact.

Results for masks are normally reported as micrograms of analyte per gram of sample (ug/g). Where an ISO 10993-7 assessment is required, results may additionally be expressed as the total residual dose delivered per device and compared against tolerable contact limits that depend on the duration of device use.

Testing Methods

Headspace Gas Chromatography (HS-GC)

Headspace gas chromatography is the reference technique for EO residue determination. A weighed portion of the cut mask sample is placed into a headspace vial, water is added as the extraction medium, and the sealed vial is equilibrated in a heated headspace sampler, typically at 60 degrees Celsius for 30 to 40 minutes. During equilibration, residual EO partitions from the sample into the vial headspace. An aliquot of the headspace gas is then injected into a gas chromatograph equipped with a flame ionization detector (FID). EO is separated on a polar or dedicated capillary column and quantified against an external calibration curve prepared from EO standard solutions. Typical chromatographic conditions include an oven temperature in the range of 60 to 100 degrees Celsius and a detector temperature of approximately 250 degrees Celsius.

Solvent Extraction Gas Chromatography

As an alternative, the sample may be extracted with water or another suitable solvent under controlled conditions, followed by direct liquid injection of the extract into the gas chromatograph. This approach, described in GB/T 14233.1, is useful for validation purposes or when headspace equipment is unavailable, although headspace injection is generally preferred because it is cleaner, faster, and reduces contamination of the chromatographic system.

Calibration, Quantification and Calculation

Quantification is performed using the external standard method. Multi-point calibration curves are constructed over the expected concentration range, and the correlation coefficient is verified to meet method requirements. The EO residue in the sample is calculated from the measured concentration in the extract, the extraction volume, and the mass of the test portion, and is reported in ug/g. For ISO 10993-7 assessments, the measured residue is converted into the total dose delivered per device and compared with the tolerable limit applicable to the intended contact duration, such as limited (less than 24 hours), prolonged, or long-term exposure.

Quality Control and Method Validation

Each analytical batch should include reagent blanks, duplicate samples, and spiked recovery checks to verify accuracy and precision. Key validation parameters include linearity of the calibration curve, limit of detection (LOD), limit of quantification (LOQ), repeatability, and recovery, with typical recovery targets of 80 to 120 percent. Proper control of laboratory background EO levels, vial sealing integrity, and headspace equilibration time is essential for reliable results.

Applications

EO residue determination supports masks manufacturers, regulators, and purchasers across the entire product lifecycle:

• Batch release testing of EO-sterilized masks prior to distribution, demonstrating conformity with the 10 ug/g requirement of GB 19083, YY 0469, and YY/T 0969.
• Regulatory registration and market access submissions in China and export markets, including technical documentation prepared under ISO 10993-7 for biological safety evaluation.
• Sterilization process validation and aeration cycle optimization, confirming that the chosen temperature, ventilation, and aeration duration reliably reduce residues below the acceptance limit.
• Market surveillance and post-market quality monitoring by regulatory authorities and institutional purchasers.
• Root cause investigation of odor complaints, adverse reaction reports, or out-of-specification findings linked to sterilization residuals.
• Stability and dissipation studies that characterize how EO residues decline during storage, supporting shelf-life justification and labeling of sterilization date information.

Testing is typically performed by accredited third-party laboratories holding ISO/IEC 17025 accreditation, or by manufacturer laboratories with validated GC capabilities.

FAQ

Why are masks sterilized with ethylene oxide instead of other methods?

EO gas sterilization is performed at low temperature and low humidity, and it penetrates packaging and porous nonwoven layers effectively. This preserves the electrostatic charging and filtration efficiency of melt-blown polypropylene, which can be degraded by moist heat or high-dose irradiation, making EO a preferred option for many disposable respiratory products.

What is the maximum permitted EO residue in masks?

Under the Chinese product standards for medical protective masks, surgical masks, and single-use medical masks, the EO residue shall not exceed 10 ug/g for products sterilized with ethylene oxide. Under ISO 10993-7, the acceptability of residues is additionally judged against tolerable total dose limits that depend on the contact duration of the device.

How long does aeration take before testing?

Aeration durations depend on the sterilization cycle, load configuration, packaging, and aeration temperature, and commonly range from several days to two weeks. EO residue testing provides objective confirmation that the aeration process has reduced residues to a compliant level, and it is a required element of sterilization validation.

How much sample is required for testing?

In general, a few whole masks or a minimum of several grams of material are sufficient for a single determination, with additional units required for duplicate testing and retention. Samples must be sealed in gas-tight packaging immediately after sampling to preserve the residual EO content.

Which analytical technique is used?

Headspace gas chromatography with flame ionization detection, performed in accordance with GB/T 14233.1, is the standard method. The results are quantified against external calibration standards and reported in micrograms per gram of sample.

Are reaction products such as ECH and EG also tested?

For masks, the regulatory focus is on EO itself, and the 10 ug/g limit applies to EO residue. Where a fuller biological safety assessment under ISO 10993-7 is required, or where materials and processing conditions suggest formation of by-products, ECH and EG may also be determined and evaluated against the applicable tolerable limits.